Viewing Study NCT04073160


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-27 @ 9:03 AM
Study NCT ID: NCT04073160
Status: WITHDRAWN
Last Update Posted: 2020-07-07
First Post: 2019-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
Sponsor: Daniel George, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module